These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38383521)

  • 41. Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature.
    Krismer AC; Dünser MW; Lindner KH; Stadlbauer KH; Mayr VD; Lienhart HG; Arntz RH; Wenzel V
    Am J Cardiovasc Drugs; 2006; 6(1):51-68. PubMed ID: 16489848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasopressin in Sepsis and Other Shock States: State of the Art.
    García-Álvarez R; Arboleda-Salazar R
    J Pers Med; 2023 Oct; 13(11):. PubMed ID: 38003863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin II for the Treatment of Vasodilatory Shock.
    Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM;
    N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
    Shankar-Hari M; Phillips GS; Levy ML; Seymour CW; Liu VX; Deutschman CS; Angus DC; Rubenfeld GD; Singer M;
    JAMA; 2016 Feb; 315(8):775-87. PubMed ID: 26903336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU.
    Quan M; Cho N; Bushell T; Mak J; Nguyen N; Litwak J; Rockwood N; Nguyen HB
    Crit Care Explor; 2022 Jan; 4(1):e0623. PubMed ID: 35072084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of Vasopressor-Induced Acute Limb Ischemia (VIALI) in Septic Shock.
    Attallah N; Hassan E; Jama AB; Jain S; Ellabban M; Gleitz R; Ali S; Chand M; Jain NK; Khan SA
    Cureus; 2022 Dec; 14(12):e33118. PubMed ID: 36742274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing of vasoactive agents and corticosteroid initiation in septic shock.
    Ammar MA; Ammar AA; Wieruszewski PM; Bissell BD; T Long M; Albert L; Khanna AK; Sacha GL
    Ann Intensive Care; 2022 May; 12(1):47. PubMed ID: 35644899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Adequate fluid resuscitation in septic shock with high catecholamine doses].
    Lewejohann JC; Braasch H; Hansen M; Zimmermann C; Muhl E; Keck T
    Med Klin Intensivmed Notfmed; 2016 Sep; 111(6):514-24. PubMed ID: 26555619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial.
    Bokoch MP; Tran AT; Brinson EL; Marcus SG; Reddy M; Sun E; Roll GR; Pardo M; Fields S; Adelmann D; Kothari RP; Legrand M
    BMJ Open; 2023 Nov; 13(11):e078713. PubMed ID: 37984940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.
    Zhong L; Ji XW; Wang HL; Zhao GM; Zhou Q; Xie B
    J Intensive Care; 2020 Oct; 8(1):83. PubMed ID: 33292658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catecholamine-Sparing Effect of Angiotensin II in an Anephric Patient With Mixed Shock After Cardiac Revascularization Surgery: A Case Report.
    Cutler NS; Khanna AK
    A A Pract; 2020 Jul; 14(9):e01266. PubMed ID: 32909718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should Vasopressors Be Started Early in Septic Shock?
    Cioccari L; Jakob SM; Takala J
    Semin Respir Crit Care Med; 2021 Oct; 42(5):683-688. PubMed ID: 34544185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
    Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH
    Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock.
    Hamzaoui O; Goury A; Teboul JL
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of patients with septic shock and high-dose vasopressor therapy.
    Auchet T; Regnier MA; Girerd N; Levy B
    Ann Intensive Care; 2017 Dec; 7(1):43. PubMed ID: 28425079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.